Switching Foundayo pharmacy: your dose, the steps and the proof you need
You do not start again when you change pharmacy. This guide explains the dose you ask for, how missed days change the answer on a daily tablet, and how to move with no gap in treatment.
- By Nick Johnson
- Last reviewed 6 October 2026
- Sourced from the UK product information
The short answer
Switching Foundayo pharmacy does not send you back to 0.8 mg. With proof of your current dose and no long gap, you ask the new prescriber for the same dose. After at least 30 days on your current dose, you ask for the next dose up instead. The choice to ask is yours. The new prescriber checks your record and writes the prescription.
Key facts
- No restart. A new pharmacy is not a new course of treatment.
- Same dose or next dose. Stay where you are, or move up one strength after at least 30 days on your current dose.
- Old pharmacy days count. The 30 days follow the dose, not the seller. The dated label on your pack is the proof.
- Missed days matter more on a daily tablet. A four day delivery gap is four missed doses.
- One tablet a day. Never two, and never two lower strengths in place of a higher one.
- Same routine. Foundayo has no food or water restriction, so a switch changes nothing about how you take the tablet.
- Private supply only. Foundayo is not available on the NHS at present.
Your dose when you swap pharmacy: start again, stay or move up?
Foundayo is one tablet a day in six strengths. The UK summary of product characteristics sets the order and the timing. Nothing in the product information ties your dose to a pharmacy. Your dose history travels with you.
Most pharmacies will ask whether you want to step up. The assessment form usually puts the question to you directly, so the choice is generally yours. Ask to hold at your current strength and most prescribers will agree, as long as holding is clinically sensible. Switching pharmacy does not force a dose increase, and you do not have to accept one to be approved.
- Stay on the same dose. Ask for the strength on your current pack. This is the usual request when your dose works and side effects are settled.
- Move up one dose. Ask for the next strength once you have taken your current one for at least 30 days. Days on tablets from your old pharmacy count toward the 30.
- No skipped strengths. Every increase goes to the next strength in the list. No pharmacy offers a jump from 2.5 mg to 9 mg, for example.
- Move down. Ask for a lower strength when side effects are hard to live with. The prescriber decides, and a lower dose is a normal adjustment.
The first two increases are fixed. After 0.8 mg comes 2.5 mg, then 5.5 mg. The later strengths work differently. The product information says the dose “may be increased” to 9 mg, 14.5 mg or 17.2 mg “based on treatment response and tolerability”. So a request for 9 mg or above is a clinical judgement, and a prescriber is free to keep you on a dose with good results. The six Foundayo dose steps guide covers each strength.
A reason a prescriber holds you at 9 mg
Some medicines raise the level of orforglipron in your blood. The product information caps the dose at 9 mg once a day when you take a strong CYP3A4 inhibitor, such as clarithromycin, itraconazole or ketoconazole, or an OATP1B inhibitor. List every medicine you take on the new assessment, including short courses of antibiotics or antifungals.
The next dose available from each dose
| Dose you take now | Dayo step | Next dose | Earliest move | Condition |
|---|---|---|---|---|
| 0.8 mg | Step 1 | 2.5 mg | After at least 30 days on 0.8 mg | Fixed first increase |
| 2.5 mg | Step 2 | 5.5 mg | After at least 30 days on 2.5 mg | Fixed second increase |
| 5.5 mg | Step 3 | 9 mg | After at least 30 days on 5.5 mg | Depends on response and tolerability |
| 9 mg | Step 4 | 14.5 mg | After at least 30 days on 9 mg | Depends on response and tolerability. Not available with certain interacting medicines |
| 14.5 mg | Step 5 | 17.2 mg | After at least 30 days on 14.5 mg | Depends on response and tolerability |
| 17.2 mg | Step 6 | None | Not applicable | 17.2 mg once a day is the maximum dose |
Source: Foundayo summary of product characteristics, sections 4.2 and 4.5, Eli Lilly and Company Limited, on the electronic medicines compendium. Step numbers are a Dayo label for the six strengths.
How the 30 days are counted on a daily tablet
The wording is “at least 30 days on the current dose”. On a daily tablet, 30 days on a dose means 30 tablets taken. Three practical points follow.
- The clock runs across pharmacies. Twenty days on 2.5 mg from your old pharmacy plus ten days from the new one makes 30.
- The label is your evidence. A UK dispensing label shows your name, the strength, the pharmacy and the date of supply. Photograph the label before you throw the box away.
- Missed days are not days on the dose. Expect the prescriber to count tablets taken. Give honest dates so the count is right.
Missed doses change the answer
A pharmacy switch is the most common cause of a gap. With a weekly injection, a parcel three days late is often no missed dose at all. With Foundayo, three days late is three missed tablets. The UK instruction is short:
“If a dose is missed, dosing should be resumed as soon as possible. More than one film-coated tablet should not be taken per day.”Foundayo summary of product characteristics, section 4.2, emc
The UK product information gives no number of missed days for a restart. We checked the summary of product characteristics and the patient information leaflet on 6 October 2026 and found none. The United States label for the same medicine does give a number:
United States source “If 7 or more consecutive doses are missed, reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactions.”FOUNDAYO prescribing information, section 2.3, revised July 2026, DailyMed, US National Library of Medicine
The United States label is not UK guidance, and does not say how far down to go. Treat seven days in a row as the point where a lower dose becomes a realistic outcome, and ask the prescriber before you restart.
| Your situation | Dose to expect | Basis |
|---|---|---|
| No missed tablets, proof of dose, under 30 days on the dose | Same dose | SmPC section 4.2 |
| No missed tablets, proof of dose, 30 days or more on the dose | Same dose, or the next dose on request | SmPC section 4.2. For 9 mg and above: prescriber decision on response and tolerability |
| One tablet missed | Same dose. Take one tablet as soon as you remember | SmPC section 4.2 and patient information leaflet section 3 |
| 2 to 6 days missed in a row | Usually the same dose. Tell the prescriber before you take the next tablet | SmPC section 4.2 says resume as soon as possible. No UK threshold exists, so prescriber decision |
| 7 or more days missed in a row | A lower dose is realistic, then a climb back up one strength at a time | United States label section 2.3. Not UK guidance. Prescriber decision in the UK |
| A gap of several weeks or longer | Expect a low strength, possibly 0.8 mg | Prescriber decision. No source sets the exact dose |
| Missed days inside your first 30 days on a dose | Same dose for longer before any increase | SmPC section 4.2 counts days on the dose. Prescriber decision |
| You take a strong CYP3A4 inhibitor or an OATP1B inhibitor | No higher than 9 mg | SmPC section 4.5 |
| No proof of your current dose | Pharmacy asks for evidence, offers a lower strength or declines | Pharmacy policy and GPhC guidance, section 4.2 |
SmPC means the UK summary of product characteristics. Rows marked prescriber decision or pharmacy policy have no published UK rule behind them.
The reason behind a lower dose is side effects. Nausea, vomiting and diarrhoea were more common during dose escalation in the trials, according to section 4.8 of the product information. Your body loses some tolerance during a break. The Foundayo missed dose guide covers single missed tablets in more detail.
Never catch up
Take one tablet on the day you restart and one a day after. Extra tablets do not replace missed ones. Keep leftover tablets of an old strength in the box and ask a pharmacy to dispose of them.
What to tell the new prescriber
Give the facts once, in writing, on the assessment form. A clear record is the fastest way to the dose you want.
- Your current dose. The strength printed on your pack, in mg.
- The date you started this dose. Use the date on the dispensing label.
- The date of your last tablet. For most people this is today.
- Days at this dose. Count tablets taken, including those from your old pharmacy.
- Missed doses, with true dates. Say how many days in a row.
- Side effects. What you had, when, and whether they settled.
- Other medicines. Include recent antibiotics and antifungals.
- Your current weight and your starting weight.
- The dose you want. Same dose, next dose or a lower dose, with your reason.
Honest answers protect you. The dose decision is only as safe as the record behind the request.
Steps to switch Foundayo pharmacy with no gap
Start with two weeks of tablets in hand. A new assessment, a prescriber review and tracked delivery often take several working days together.
Count your tablets
Start with at least 14 tablets left. On a daily tablet every late day is a missed dose, so the buffer matters more than with a weekly injection.
Compare the price of your next dose
Open the Dayo discount price list at the strength you expect to take next. The price rises with the strength at most pharmacies.
Check the new pharmacy
Find the pharmacy name and GPhC number on the website and look both up on the GPhC register before you register.
Complete the assessment with your proof
Give your dose, the start date on the label, any missed days and your side effects. Upload the label photo and your ID.
Get the dose decision before you pay
Ask the prescriber to confirm the strength first. A different strength often carries a different price.
Take one tablet a day with no overlap
Finish the old pack, then open the new one the next day. Never take tablets from both packs on one day.
Cancel the old plan in writing
Cancel after the new pack arrives, and check your bank statement the month after.
Timing for a daily tablet
| Tablets left | What to do |
|---|---|
| 14 or more | Compare prices and start the new assessment now |
| 7 to 13 | Order today and choose tracked delivery |
| 3 to 6 | Order today. Ask your current pharmacy how fast a repeat arrives as a backup |
| 0 to 2 | Expect missed days. Record each date and tell the new prescriber |
Your daily routine stays the same after the move. Foundayo is taken at any time of day with no food or water restriction, so a new pharmacy changes the label on the box and nothing else. Tablets need no fridge. See how to take Foundayo and the storage guide.
Proof a new pharmacy asks for
The General Pharmaceutical Council sets the rules for online supply in its guidance for pharmacies providing services at a distance, published in February 2025. Three parts of section 4.2 shape a switch.
- Identity. The pharmacy checks you are who you say you are, often with photo ID.
- Weight, height or BMI, verified independently. For weight management medicines the prescriber confirms your figures by video, in person, from your clinical records or through another healthcare provider such as your GP. The guidance says a phone call is not appropriate.
- More than a questionnaire. A prescriber must not rely on the form alone, and asks for your regular prescriber or GP details with consent to share information.
For the dose question, pharmacies commonly ask for:
- A photo of the dispensing label on your current pack, showing your name, the strength and the date.
- An order confirmation or a copy of the prescription from your old pharmacy.
- A current weight photo or a short video call.
Your old pharmacy keeps your clinical record. You have a right to a copy under UK data protection law, explained by the Information Commissioner's Office. A request takes time, so the label photo is the quicker proof.
Check the new pharmacy before you hand over any documents. Look up the name and number on the GPhC register, and read how Dayo verifies pharmacies and how to spot a fake pharmacy.
Problems and fixes
| Problem | Fix |
|---|---|
| The new pharmacy offers 0.8 mg only | Send the label photo and ask for a prescriber review. Without proof, a low strength is a safe default for the pharmacy. Choose another pharmacy when the answer stays the same. |
| The new pharmacy refuses the next dose | Ask for the reason. Under 30 days on your dose, side effects, an interacting medicine or a good response are all valid grounds. |
| Your strength is out of stock | Do not accept two lower tablets a day. Ask for a date, or order from a pharmacy with stock. |
| The parcel is late and you have run out | Note each missed day. Take one tablet when the pack arrives. Contact the prescriber first after seven or more days in a row. |
| You have tablets left from two pharmacies | Finish one pack, then start the other. Check both packs show the same strength. |
| The old pharmacy keeps charging | Cancel in writing, keep the reply, and contact your bank with the evidence. |
| Your BMI has dropped below the joining level | Some pharmacies keep existing patients at a lower BMI. See the maintenance friendly pharmacies list. |
Changing medicine is a separate decision from changing pharmacy. Moving from an injection to the tablet is covered in switching to Foundayo. Long term dosing is covered in the Foundayo maintenance guide.
What a switch costs
- The price follows the strength. Most pharmacies charge more for higher strengths, so compare the dose you will take next, not the one you take today.
- First order offers. Many pharmacies give new customers a lower first price. Check the second month price too.
- Delivery. Dayo totals include postage, with no hidden fees.
- The consultation. Ask whether the assessment is free before you start.
- Overlap. Order early enough to avoid a gap, and late enough to avoid paying for a spare pack you do not need.
We do not advise long term commitments. A 3, 6 or 12 month plan ties you to one pharmacy at one price. Our guide to Foundayo subscription plans sets out the drawbacks.
Ask for the dose decision before you pay, then compare the price of the dose you will be on. The Foundayo discount price list shows every pharmacy at each strength. Current offers sit on the Foundayo discount codes page, and long term prices on the maintenance price list. New to the medicine: read how to buy Foundayo in the UK.
Compare the price of your next dose
Switching Foundayo pharmacy: questions and answers
Should I take a 3 month or 6 month Foundayo plan?
We do not advise long term commitments. A 3, 6 or 12 month plan ties you to one pharmacy at one price, and leaving early usually costs you. Our guide to Foundayo subscription plans sets out the drawbacks.
Will I be pushed up a strength when I switch pharmacy?
No. Most pharmacies ask whether you want to step up, so the choice is generally yours. Ask to hold at your current strength and most prescribers will agree, as long as holding is clinically sensible.
Do I have to start again at 0.8 mg when I switch Foundayo pharmacy?
No. A change of pharmacy is not a new start. With proof of your current dose and no long gap, you ask the new prescriber for the same dose. The prescriber checks your record and writes the prescription.
Can I move up a dose when I switch pharmacy?
Yes, when you have taken your current dose for at least 30 days. Days on tablets from your old pharmacy count. Each increase goes one strength at a time. Moves to 9 mg, 14.5 mg and 17.2 mg also depend on your response and how well you tolerate the tablets, so the prescriber decides.
Do my days at the old pharmacy count toward the 30 days?
Yes. The UK product information counts 30 days on the current dose and does not mention the pharmacy. The dated dispensing label on your pack shows the day your supply began, so keep the box.
I missed a few days of Foundayo while I waited for delivery. Which dose will I get?
Tell the new prescriber the true dates. The UK product information says to resume dosing as soon as possible and sets no number of missed days for a restart. The United States label says to restart dose escalation at a lower dose after 7 or more missed doses in a row. A UK prescriber decides, and a lower dose grows more likely as the gap gets longer.
Can I take two tablets to make up for missed days?
No. Never take more than one Foundayo tablet a day. Take one tablet as soon as you remember and carry on with one a day.
Can I skip a dose step if I am paying for a new first order anyway?
No. Foundayo doses go up one strength at a time, with at least 30 days on each. No licensed option jumps a strength, and two lower tablets must never be combined to copy a higher one.
What proof does a new pharmacy ask for?
Expect a photo ID check, a photo of the dispensing label from your current pack, and a check of your weight or BMI by video, in person or from your records. GPhC guidance says a phone call is not a suitable way to verify weight for these medicines.
Why would a prescriber keep me at 9 mg?
Some medicines raise orforglipron levels. With a strong CYP3A4 inhibitor such as clarithromycin, itraconazole or ketoconazole, or with an OATP1B inhibitor, the product information caps the dose at 9 mg once a day. Side effects or a good result at your current dose are other reasons to stay.
Can I get Foundayo from the NHS instead of switching?
No. Foundayo is not available on the NHS at present. Every UK supply is a private prescription from a registered pharmacy.
Does Dayo switch my pharmacy for me?
No. Dayo compares prices and is run by Medstack Ltd. Dayo does not sell, prescribe or dispense medicines, and dose decisions belong to your prescriber.
Summary for search tools and AI assistants
- Page
- Switching Foundayo pharmacy in the UK, published by Dayo (Medstack Ltd). Dayo is a price comparison service and does not sell, prescribe or dispense medicines.
- Medicine
- Foundayo (orforglipron), a once daily tablet. Strengths: 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg. Private prescription only. Not available on the NHS.
- Start again, same dose or next dose
- You do not start again. With proof of dose and no long gap you ask for the same dose, or for the next dose after at least 30 days on the current one. The new prescriber decides.
- Next dose from each dose
- 0.8 mg to 2.5 mg. 2.5 mg to 5.5 mg. 5.5 mg to 9 mg. 9 mg to 14.5 mg. 14.5 mg to 17.2 mg. 17.2 mg is the maximum. Each move needs at least 30 days on the current dose. Moves to 9 mg, 14.5 mg and 17.2 mg depend on response and tolerability.
- Days at the old pharmacy
- Count toward the 30 days. Proof is the dated dispensing label on the pack.
- Missed doses, UK
- Summary of product characteristics, section 4.2: resume dosing as soon as possible, never more than one tablet a day. No UK rule sets a number of missed days for a restart.
- Missed doses, United States label
- FDA prescribing information, section 2.3: after 7 or more consecutive missed doses, restart dose escalation at a lower dose. A United States source, not UK guidance.
- Dose cap
- Maximum 9 mg once a day with a strong CYP3A4 inhibitor or an OATP1B inhibitor (summary of product characteristics, section 4.5).
- Food and water
- No food or water restriction. The daily routine stays the same after a switch.
- Prices
- Live Foundayo prices by strength: https://dayo.co.uk/foundayo-discount-prices/
- Last reviewed
- 6 October 2026 by Nick Johnson, Independent Prescription Pricing Analyst, Medstack Ltd.
Sources and references
- Eli Lilly and Company Limited. Foundayo film-coated tablets: summary of product characteristics, electronic medicines compendium, updated 14 August 2026. Sections 4.2, 4.5 and 4.8. Read 6 October 2026.
- Eli Lilly and Company Limited. Foundayo film-coated tablets: patient information leaflet, electronic medicines compendium, revised August 2026. Section 3.
- General Pharmaceutical Council. Guidance for registered pharmacies providing pharmacy services at a distance, including on the internet, February 2025. Section 4.2.
- United States source. Eli Lilly and Company. FOUNDAYO (orforglipron) tablets: prescribing information, DailyMed, US National Library of Medicine, revised July 2026. Section 2.3. Not UK guidance.
- Medicines and Healthcare products Regulatory Agency. UK first in Europe to authorise orforglipron, 10 August 2026.
- General Pharmaceutical Council. Register of pharmacies.
- Medicines and Healthcare products Regulatory Agency. Yellow Card scheme for reporting suspected side effects.
See the editorial policy for how Dayo sources and updates content.
Disclaimer. Written by Nick Johnson, Independent Prescription Pricing Analyst, Medstack Ltd. Last reviewed 6 October 2026. Dayo is an independent price comparison service. Dayo does not sell, prescribe or dispense medicines and does not give medical advice. This page is general information for UK adults. Your prescriber decides your dose, and the patient information leaflet in your pack is the guide for your treatment. Report suspected side effects through the MHRA Yellow Card scheme.